Genomind helps providers better select and manage medications using a patient’s genetics.
In the US each year, providers write billions of prescriptions for over 20,000 FDA-approved drugs, often relying on a “trial and error” approach to manage a patient’s medications – causing millions of patients to suffer preventable health complications every year.
Genomind is a lab testing and technology platform that empowers providers with prescribing recommendations based on a patient’s genetics (captured with a simple cheek swab). Genomind minimizes the guessing game in medication selection and management, enabling providers to pair their existing clinical expertise with a precise and personalized treatment plan for every patient.
Genomind Patient Report
